ONCOLOGY TREATMENT IN SWITZERLAND

Cancer treatment in Switzerland is recognized as one of the most successful in the world. The doctors of this country manage to cope with complex, often recognized as hopeless in other countries, cases of cancer.

The budget of the Swiss healthcare system is 12.3% of the country's total GDP - one of the largest figures among European countries. The state annually allocates 35% of funds for cancer research.

Leading cancer drug companies Novartis and Roche are based in Switzerland and invest in R&D. The country is an international leader in genetic research and DNA analysis.

The effectiveness of treatment is due to the use of the latest achievements and innovative technologies, as well as the high level of professionalism of oncologists. The country has strict requirements for the level of qualification of a doctor, so the patient can be sure that a highly qualified specialist will take care of his health.

Differences in approaches to treatment in Switzerland and the CIS countries are noticeable from the very beginning, even at the stage of diagnosis. To determine the type, stage, degree of malignancy of the tumor in Swiss clinics, the most modern tests are carried out, which allows for a 100% correct diagnosis.

Each patient is treated individually. The treatment plan is compiled by a multidisciplinary team of doctors after a preliminary qualitative diagnosis. Those types of therapy that will give the greatest effect are selected. Much attention is also paid to protecting the patient from severe complications and side effects.

The professors of the University Hospital Zurich specialize in the diagnosis and treatment of oncological diseases of all organ systems, and also offer the diagnosis and treatment of benign blood changes. Thanks to the latest laboratory analysis technologies, specialists are able to establish accurate diagnoses and prescribe individualized therapy.

The Cancer Center cooperates closely with German and foreign partners, which guarantees the excellent quality of preventive measures, diagnostics, treatment, postoperative follow-up and medical genetic counseling. As a university institution, the Cancer Center conducts basic and clinical research aimed at the continuous improvement of medicine.

In one of the largest network of private clinics in Switzerland, Genolier has several specialized oncology centers in different parts of the country. These are the Genolier Clinic, the O-Vive Cancer Center, the Bethanien Clinic in Zurich.

The oncology department of the Hirslanden Clinic specializes in the treatment of breast cancer, skin cancer, brain tumors, liver cancer, colon cancer, lung cancer, prostate cancer, cervical cancer, and pancreatic cancer.

In order to establish an accurate diagnosis in case of suspected cancer, the doctor must conduct a complete examination of the patient. For this, oncologists use a variety of diagnostic methods:

MRI (magnetic resonance imaging)
CT (computed tomography)
For diagnosing breast cancer: mammography
To diagnose prostate cancer: a blood test for PSA (prostate specific antigen)
extensive blood tests
biopsy
molecular genetic research
Oncologists have state-of-the-art medical equipment that provides accurate and quick diagnosis of possible cancers.

The diagnostic program can be compiled on the basis of extracts you already have.

The cost of treatment is fully consistent with the quality of therapy and the service provided by clinics in this country. The price is determined based on the type of cancer, its prevalence and stage. The operation to remove a brain tumor costs about 60 thousand francs, the treatment of prostate cancer - about 35 thousand francs, the surgical treatment of uterine cancer - about 30 thousand francs.

The total cost depends on the number of procedures, the type of surgery, the length of the patient's stay in the clinic.

The treatment program is compiled individually for each patient; the cost is determined individually after diagnosis and consultation with a specialist.

Private and public clinics in Zurich and Geneva are ISO certified, which confirms their compliance with high standards of medical care. Some of them are members of the prestigious association Swiss Leading Hospitals.